Showing 261 - 280 results of 346 for search '"ovarian cancer"', query time: 0.06s Refine Results
  1. 261

    Fluorescence Lifetime Imaging for Quantification of Targeted Drug Delivery in Varying Tumor Microenvironments by Amit Verma, Vikas Pandey, Catherine Sherry, Taylor Humphrey, Christopher James, Kailie Matteson, Jason T. Smith, Alena Rudkouskaya, Xavier Intes, Margarida Barroso

    Published 2025-01-01
    “…Near‐infrared (NIR) fluorescence lifetime (FLI) Forster Resonance Energy Transfer (FRET) is performed to measure TZM‐HER2 binding, using in vitro microscopy and in vivo widefield macroscopy, in HER2 overexpressing breast and ovarian cancer cells and tumor xenografts, respectively. …”
    Get full text
    Article
  2. 262

    Intraoperative Diagnosis: Imprint Cytology and Frozen Section in Ovarian Tumor, Averting Additional Surgery by Kiran Lanjewar, Sanjay Deotale, Sunita Vagha, Sudhanshu Dakre

    Published 2024-12-01
    “…A granulosa cell tumor (GCT) is a type of ovarian cancer that constitutes approximately 10% of all ovarian malignancies. …”
    Get full text
    Article
  3. 263

    Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers by Daehwan Kim, Heekyung Chung, Wen Liu, Kangjin Jeong, Tugba Y. Ozmen, Furkan Ozmen, Matthew J. Rames, Sangyub Kim, Xiao Guo, Nathan Jameson, Petrus R. de Jong, Steven Yea, Laurie Harford, Jiali Li, Cara A. Mathews, Deborah B. Doroshow, Vincent J. Charles, Doris Kim, Kimberlee Fischer, Ahmed A. Samatar, Adrian Jubb, Kevin D. Bunker, Kimberly Blackwell, Fiona Simpkins, Funda Meric-Bernstam, Gordon B. Mills, Olivier Harismendy, Jianhui Ma, Mark R. Lackner

    Published 2025-01-01
    “…Here we characterized the relationship between Cyclin E1/CDK2 activation and sensitivity to the selective WEE1 inhibitor azenosertib. We found that ovarian cancer cell lines with high levels of endogenous Cyclin E1 expression or forced overexpression were exquisitely sensitive to azenosertib and these results extended to in vivo models of ovarian and uterine serous carcinoma. …”
    Get full text
    Article
  4. 264

    Invasive micropapillary carcinoma of the breast and bilateral ovarian mature cystic teratoma with benign Brenner tumor in a postmenopausal woman – An uncommon occurrence by Pavithra Ayyanar, Suvradeep Mitra, Mohammed Imaduddin, Dillip K. Muduly

    Published 2023-01-01
    “…The synchronous occurrence of bilateral ovarian tumors and breast malignancy often raise the suspicion of a Krukenberg tumor or a hereditary breast and ovarian cancer syndrome, both of which are uncommon in clinical practice. …”
    Get full text
    Article
  5. 265

    Aortic Arch Floating Thrombus Complicated by Distal Embolization in a Patient with Malignancy by Konstantinos Tigkiropoulos, Dimitrios Karamanos, Marianthi Tympanidou, Nikolaos Saratzis, Ioannis Lazaridis

    Published 2018-01-01
    “…We present the case of a 52-years-old patient with ovarian cancer and aortic arch floating thrombus who initially managed with low molecular weight heparin and eventually undergone surgical thrombectomy of left external iliac and common femoral artery due to acute ischemia of left lower leg.…”
    Get full text
    Article
  6. 266

    An Unusual Case of Synchronous Carcinoid of Ovary and Gall Bladder by Rupali Bassi, Raksha Arora, Sangeeta Bhasin, Nita Khurana

    Published 2013-01-01
    “…An asymptomatic 45-years-old perimenopausal lady was diagnosed to have a metastatic ovarian cancer, but on laparotomy she was found to have a primary synchronous metastatic gall bladder as well. …”
    Get full text
    Article
  7. 267

    Technique of Peritoneal Catheter Placement under Fluroscopic Guidance by Ahmed Kamel Abdel-Aal, Santhosh Gaddikeri, Souheil Saddekni

    Published 2011-01-01
    “…Other uses of this catheter include intraperitoneal chemotherapy and gene therapy for ovarian cancer and draining of uncontrolled refractory ascites in patients with liver cirrhosis. …”
    Get full text
    Article
  8. 268

    The role of tribbles homolog 2 in cell proliferation by Wenkang Zhang, Mingkang Li, Minhao Zhang, Gaoliang Yan, Chengchun Tang

    Published 2025-01-01
    “…TRIB2 is not only involved in the physiological proliferation of cells (granulosa cells, myoblasts, naive T cells, and thymocytes) during normal development but also in the pathological proliferation of vascular smooth muscle cells and a variety of cancer cells (lung cancer cells, liver cancer cells, leukemia cells, pancreatic cancer cells, gastric cancer cells, prostate cancer cells, thyroid cancer cells, cervical cancer cells, melanoma cells, colorectal cancer cells, ovarian cancer cells and osteosarcoma cells) under disease conditions. …”
    Get full text
    Article
  9. 269

    Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma by Mustafa M. Mohammad, Kostas N. Syrigos, M. Wasif Saif

    Published 2013-01-01
    “…Vinorelbine (Navelbine, VRL) is commonly used for platinum-resistant ovarian cancer and has been shown to be effective in patients with recurrent primary peritoneal carcinoma. …”
    Get full text
    Article
  10. 270

    Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics Analysis by Bernard Friedenson

    Published 2025-01-01
    “…ResultsChromosome breakpoints in breast and ovarian cancer clustered around breakpoints in EBV-associated cancers. …”
    Get full text
    Article
  11. 271

    Malignant Transformation of Mature Cystic Teratoma Diagnosed after a 10-Year Interval by Mariko Jitsumori, Satoru Munakata, Toshiya Yamamoto

    Published 2017-01-01
    “…The postoperative pathological diagnosis was squamous cell carcinoma arising from teratoma, and the postoperative clinical diagnosis was stage IA ovarian cancer. It was assumed that the mature cystic teratoma which had been detected in the right ovary 10 years earlier had undergone malignant transformation.…”
    Get full text
    Article
  12. 272

    REV7: a small but mighty regulator of genome maintenance and cancer development by Lara R. Maggs, Mitch McVey

    Published 2025-01-01
    “…Given that genome instability is a hallmark of cancer, it is unsurprising that REV7, with its numerous genome maintenance roles, is implicated in multiple malignancies, including ovarian cancer, glioma, breast cancer, malignant melanoma, and small-cell lung cancer. …”
    Get full text
    Article
  13. 273

    Ovarian Epithelial Cancer Stem Cells by Irena Conic, Irena Dimov, Desanka Tasic-Dimov, Biljana Djordjevic, Vladisav Stefanovic

    Published 2011-01-01
    “…The realization of epithelial ovarian cancer (EOC) as a CSC-related disease has the potential to change approaches in the treatment of this devastating disease dramatically. …”
    Get full text
    Article
  14. 274

    Clear Cell Carcinoma of the Endometrium Causing Paraneoplastic Retinopathy: Case Report and Review of the Literature by Paulina Cybulska, Eduardo V. Navajas, Filiberto Altomare, Marcus Q. Bernardini

    Published 2011-01-01
    “…Of these 28 cases, 14 patients were diagnosed with endometrial cancer, 7 with ovarian cancer, 5 with cervical cancer, 1 fallopian tube cancer and 1 with concomitant endometrial and ovarian cancers. …”
    Get full text
    Article
  15. 275

    Combined Effect of Lentinan and Cisplatin on Cytokines IL-6, TNF-α, and TGF-β in Tumor Therapy by Xu-dong Liu, Min Li, Wan-xiang Li, Qing-yu Wang, Hong-xia Zhang

    Published 2019-01-01
    “…Furthermore, it was proved that the combined treatment of lentinan and cisplatin enhanced the inhibitory effect of cisplatin on the expression of IL-6, TNF- α, TGF-β and tumor growth in mice bearing human ovarian cancer xenograft, human prostate tumor xenograft, and human non-small cell lung cancer xenograft.…”
    Get full text
    Article
  16. 276

    Synthesis and biological evaluation of 4-(1H-imidazol-2-yl)-2-(pyrimidin-5-yl)oxazoles as potent anticancer agents by Divya Komirishetti, Vasantha Mittapelli

    Published 2025-01-01
    “…Further, the biological applications of the newly prepared compounds 11a–j were evaluated against four human cancer cell lines including breast cancer (MCF-7), lung cancer (A549), colon cancer (Colo-205) and ovarian cancer (A2780), using the standard MTT assay, with etoposide as the positive control. …”
    Get full text
    Article
  17. 277

    Renal Cell Carcinoma Metastasis from Biopsy Associated Hematoma Disruption during Robotic Partial Nephrectomy by Christopher Caputo, Ziho Lee, Andrew Harbin, Daniel Eun

    Published 2014-01-01
    “…We describe a case in which a patient with a past medical history of ovarian cancer received a diagnostic renal biopsy for an incidentally discovered renal mass. …”
    Get full text
    Article
  18. 278

    Prognostic factors in hereditary breast cancer: A review by Ziske Maritska, Sarmoko

    Published 2024-08-01
    “…However, the risk of developing other malignancies, such as ovarian cancer and melanoma, remains elevated in BRCA mutation carriers. …”
    Get full text
    Article
  19. 279

    A reproducible framework for monitoring the impact of randomized clinical trials on clinical practice using large-scale real-world data: application to gynaecological surgical tria... by Floriane Jochum, Madeleine Doll, Anne-Sophie Hamy, Lou Donval, Paul Gougis, Élise Dumas, Lise Lecointre, Thomas Gaillard, Fabien Reyal, Fabrice Lecuru, Cherif Akladios, Enora Laas

    Published 2025-02-01
    “…We analysed patients who underwent radical hysterectomy for cervical cancer (2013–2022) and patients who underwent cytoreductive surgery for ovarian cancer (2014–2022). Bayesian structural time series analysis assessed the causal effects of the LACC and LION trials on the discontinuation of minimally invasive surgery (MIS) and lymphadenectomy, respectively. …”
    Get full text
    Article
  20. 280

    Anticancer, Antibacterial, Antioxidant, and DNA-Binding Study of Metal-Phenalenyl Complexes by Subhadeep Sen, Nilkanta Chowdhury, Tae-Wan Kim, Mohuya Paul, Dilip Debnath, Seob Jeon, Angshuman Bagchi, Jungkyun Im, Goutam Biswas

    Published 2022-01-01
    “…In this study, the anticancer properties of such complexes were investigated in ovarian cancer cells (SKOV3 and HEY A8), and the cytotoxicity was comparable to that of other platinum-based drugs. …”
    Get full text
    Article